Cervarix (Human Papillomavirus Vaccine (HPV) Types 16 and 18 - Recombinant, AS04 Adjuvanted) is available as an injection, 0.5mL per dose. Cervarix is private purchase medicine. You will need to pay for this vaccine. Prescription Medicine for the prevention of cervical cancer by protecting against cervical HPV infections, Pap smear abnormalities and pre-cancerous lesions caused by HPV types 16 and 18 in females from 10 to 45 years of age. Use strictly as directed. Do not have Cervarix injections if you are allergic to any component of the vaccine.
Tell your doctor if you have a fever, a low blood platelet count, or any blood clotting disorders. Cervarix is not intended to treat cervical HPV infections or lesions present at the time of vaccination or to prevent the progression of established lesions present at the time of vaccination. Cervarix may not prevent HPV infection and related clinical outcomes due to other cancer-causing HPV types. Vaccination is not a substitute for regular Pap screening or for taking precautions against exposure to HPV and sexually transmitted diseases. There is little information to recommend the use of Cervarix during pregnancy; therefore vaccination should be postponed until after pregnancy. Side Effects: Some common reactions observed after receiving the vaccine were pain, redness and swelling at the injection site, aching muscles or muscle tenderness, headache, fatigue, joint pain, itching, rash, nausea, vomiting, diarrhoea and fever.
If symptoms continue or you have side effects, see your doctor, pharmacist or health professional. Additional Consumer Medicine Information for Cervarix is available at www.medsafe.govt.nz.
Prices for Cervarix may vary across doctors’ surgeries. Other normal doctor's office visit fees apply. Ask your doctor if Cervarix is right for you.
Cervarix is a trade mark of the GlaxoSmithKline group of companies.
Marketed by GlaxoSmithKline NZ Limited, Auckland. TAPS DA89KH/08MY/066